Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-09-30

Clinical Trial Update: Intravenous Acetaminophen as Adjuvant Therapy for Pain Control in Geriatric Hip Fracture Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravenous acetaminophen as adjuvant therapy for pain control in geriatric hip fracture patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetaminophen (intravenous) (acetaminophen)

Snippet

Sponsor: Lancaster General Hospital | Conditions: Pain, Hip Fracture | Phase 3 | Status: WITHDRAWN